176 related articles for article (PubMed ID: 28945024)
1. [Pathogenesis and treatment of insulin resistance in chronic kidney disease and interventional effects of Chinese herbal medicine].
Wu W; Yang JJ; Wan YG; Tu Y; Shi G; Han WB; Liu BH; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jan; 42(1):49-55. PubMed ID: 28945024
[TBL] [Abstract][Full Text] [Related]
2. [Molecular mechanisms of insulin resistance and interventional effects of Chinese herbal medicine].
Yee HY; Yang JJ; Wan YG; Chong FL; Wu W; Long Y; Han WB; Liu YL; Tu Y; Yao J
Zhongguo Zhong Yao Za Zhi; 2019 Apr; 44(7):1289-1294. PubMed ID: 31090283
[TBL] [Abstract][Full Text] [Related]
3. [Molecular mechanisms of autophagy in regulating renal aging and interventional effects of Chinese herbal medicine].
Tu Y; Sun W; Chen DP; Wan YG; Wu W; Yao J
Zhongguo Zhong Yao Za Zhi; 2016 Nov; 41(21):3914-3918. PubMed ID: 28929674
[TBL] [Abstract][Full Text] [Related]
4. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the mechanisms of action of Shenkang in chronic kidney disease: A network pharmacology study and experimental validation.
Qin T; Wu L; Hua Q; Song Z; Pan Y; Liu T
J Ethnopharmacol; 2020 Jan; 246():112128. PubMed ID: 31386888
[TBL] [Abstract][Full Text] [Related]
6. [Regulative mechanisms of mammalian target of rapamycin signaling pathway in glomerular hypertrophy in diabetic nephropathy and interventional effects of Chinese herbal medicine].
Yang JJ; Huang YR; Wan YG; Shen SM; Mao ZM; Wu W; Yao J
Zhongguo Zhong Yao Za Zhi; 2015 Aug; 40(16):3125-31. PubMed ID: 26790279
[TBL] [Abstract][Full Text] [Related]
7. [Effects and mechanisms of Supplemented Gegen Qinlian Decoction Formula against podocyte pyroptosis and insulin resistance in model rats with diabetic kidney disease].
Wang MZ; Yue LJ; Wan YG; Huang H; Wu W; Tu Y; Liu BH; Fang QJ; Yuan CC; Wang J; Li H; Wan ZY
Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4471-4479. PubMed ID: 34581052
[TBL] [Abstract][Full Text] [Related]
8. Insulin resistance as a therapeutic target for chronic kidney disease.
Teta D
J Ren Nutr; 2015 Mar; 25(2):226-9. PubMed ID: 25511524
[TBL] [Abstract][Full Text] [Related]
9. Insulin resistance in chronic kidney disease: a systematic review.
Spoto B; Pisano A; Zoccali C
Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
[TBL] [Abstract][Full Text] [Related]
10. Renal insulin resistance in type 2 diabetes mellitus and progression of chronic kidney disease: potential pathogenic mechanisms.
Alqallaf A; Swan P; Docherty NG
Expert Rev Endocrinol Metab; 2022 Nov; 17(6):523-532. PubMed ID: 36203374
[TBL] [Abstract][Full Text] [Related]
11. [Pathomechanisms of podocyte injury in diabetic nephropathy and interventional effects of Chinese herbal medicine].
Shi G; Mao ZM; Wan YG; Shen SM; Wu W; Yang JJ; Yao J
Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(13):2416-2421. PubMed ID: 28905562
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in chronic kidney disease is ameliorated by spironolactone in rats and humans.
Hosoya K; Minakuchi H; Wakino S; Fujimura K; Hasegawa K; Komatsu M; Yoshifuji A; Futatsugi K; Shinozuka K; Washida N; Kanda T; Tokuyama H; Hayashi K; Itoh H
Kidney Int; 2015 Apr; 87(4):749-60. PubMed ID: 25337775
[TBL] [Abstract][Full Text] [Related]
13. Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats.
Xu Z; Zhang L; Li J; Zhao Y; Chen X
Kidney Blood Press Res; 2018; 43(4):1199-1211. PubMed ID: 30071523
[TBL] [Abstract][Full Text] [Related]
14. Insulin Resistance and Type 2 Diabetes Mellitus: An Ultimatum to Renal Physiology.
Sinha S; Haque M
Cureus; 2022 Sep; 14(9):e28944. PubMed ID: 36111327
[TBL] [Abstract][Full Text] [Related]
15. [Regulatory mechanism of NF-kappaB signaling pathway on renal tissue inflammation in chronic kidney disease and interventional effect of traditional Chinese medicine].
Liu H; Sun W; Wan YG; Tu Y; Yu BY; Hu H
Zhongguo Zhong Yao Za Zhi; 2013 Dec; 38(24):4246-51. PubMed ID: 24791524
[TBL] [Abstract][Full Text] [Related]
16. The effect of Liuwei Dihuang decoction on PI3K/Akt signaling pathway in liver of type 2 diabetes mellitus (T2DM) rats with insulin resistance.
Dai B; Wu Q; Zeng C; Zhang J; Cao L; Xiao Z; Yang M
J Ethnopharmacol; 2016 Nov; 192():382-389. PubMed ID: 27401286
[TBL] [Abstract][Full Text] [Related]
17. [Regulative mechanisms of tubular epithelial to mesenchymal transition and interventional effects of Chinese herbal medicine].
Yin XJ; Sun W; Wan YG; Tu Y; Liu H; Yu BY
Zhongguo Zhong Yao Za Zhi; 2013 Mar; 38(5):648-52. PubMed ID: 23724667
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-β/Smad and NF-κB signaling pathway in 5/6 nephrectomized rats.
Wang DT; Huang RH; Cheng X; Zhang ZH; Yang YJ; Lin X
Int Immunopharmacol; 2015 May; 26(1):4-12. PubMed ID: 25744602
[TBL] [Abstract][Full Text] [Related]
19. High Glucose Impairs Insulin Signaling in the Glomerulus: An In Vitro and Ex Vivo Approach.
Katsoulieris EN; Drossopoulou GI; Kotsopoulou ES; Vlahakos DV; Lianos EA; Tsilibary EC
PLoS One; 2016; 11(7):e0158873. PubMed ID: 27434075
[TBL] [Abstract][Full Text] [Related]
20. Correction of metabolic acidosis improves insulin resistance in chronic kidney disease.
Bellasi A; Di Micco L; Santoro D; Marzocco S; De Simone E; Cozzolino M; Di Lullo L; Guastaferro P; Di Iorio B;
BMC Nephrol; 2016 Oct; 17(1):158. PubMed ID: 27770799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
